Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action

Conclusions and Implications:
Because exogenous mediators of protein SNO or denitrosylation can substantially affect the development or progression of disease, this may call for new utility of nebivolol.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - August 4, 2016 Category: Cardiology Authors: Jiang, H., Polhemus, D. J., Islam, K. N., Torregrossa, A. C., Li, Z., Potts, A., Lefer, D. J., Bryan, N. S. Tags: Experimental Studies Source Type: research